Clinical Trials · NCT00510224
Sandostatin for Patients With Androgen Independent Prostate Cancer
- Phase
- Phase 2
- Recruitment status
- Terminated
- Sponsor
- University of California, San Francisco
- Enrollment
- 13
- Start date
- Jul 2007
- Locations
- 1 site, United States
- Primary endpoint
- PSA Response